General AML

Eduardo Rego | EHA 2018 | Overcoming the main challenges for treating AML/APL in developing countries


Eduardo Rego from University of São Paulo, São Paulo, BR, comments on the challenges facing physicians treating of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL) at the 2018 European Hematology Association (EHA) meeting. He highlighted that the delay in approval of novel agents and cost are some of the main problems facing physicians in developing countries. 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF